Barbara Saxty

1.4k total citations
33 papers, 1.1k citations indexed

About

Barbara Saxty is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Barbara Saxty has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Physiology. Recurrent topics in Barbara Saxty's work include PARP inhibition in cancer therapy (8 papers), Calcium signaling and nucleotide metabolism (6 papers) and DNA Repair Mechanisms (3 papers). Barbara Saxty is often cited by papers focused on PARP inhibition in cancer therapy (8 papers), Calcium signaling and nucleotide metabolism (6 papers) and DNA Repair Mechanisms (3 papers). Barbara Saxty collaborates with scholars based in United Kingdom, United States and Switzerland. Barbara Saxty's co-authors include Simon A. Osborne, Chido Mpamhanga, Ian G. Ganley, Ahmad M. Kamal, Timothy N. C. Wells, Mariann Bienz, David Whalley, Deepti Gupta, Trevor J. Rutherford and Dmitry B. Veprintsev and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Barbara Saxty

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Saxty United Kingdom 16 689 386 201 146 134 33 1.1k
Paola Lo Surdo Italy 19 1.2k 1.8× 151 0.4× 308 1.5× 115 0.8× 111 0.8× 38 1.9k
John P. Durham United States 17 876 1.3× 115 0.3× 130 0.6× 136 0.9× 74 0.6× 41 1.1k
Dasheng Wang United States 18 844 1.2× 136 0.4× 270 1.3× 59 0.4× 182 1.4× 31 1.2k
Gregory Tombline United States 23 956 1.4× 94 0.2× 619 3.1× 155 1.1× 112 0.8× 41 1.6k
Pierre Beauparlant Canada 16 874 1.3× 196 0.5× 329 1.6× 78 0.5× 394 2.9× 25 1.6k
Yigang Wang China 25 1.1k 1.6× 339 0.9× 544 2.7× 69 0.5× 273 2.0× 90 1.8k
Raffaele Frazzi Italy 17 454 0.7× 164 0.4× 130 0.6× 91 0.6× 163 1.2× 39 937
Benjamin T. Vroman United States 20 1.1k 1.5× 207 0.5× 732 3.6× 103 0.7× 131 1.0× 24 1.8k
Halime Kalkavan United States 10 719 1.0× 256 0.7× 188 0.9× 27 0.2× 173 1.3× 16 1.1k
Mustapha Aoubala France 15 648 0.9× 306 0.8× 410 2.0× 21 0.1× 114 0.9× 23 1.2k

Countries citing papers authored by Barbara Saxty

Since Specialization
Citations

This map shows the geographic impact of Barbara Saxty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Saxty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Saxty more than expected).

Fields of papers citing papers by Barbara Saxty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Saxty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Saxty. The network helps show where Barbara Saxty may publish in the future.

Co-authorship network of co-authors of Barbara Saxty

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Saxty. A scholar is included among the top collaborators of Barbara Saxty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Saxty. Barbara Saxty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marín‐Rubio, José Luis, Rachel E. Heap, María Emilia Dueñas, et al.. (2022). A Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Assay Identifies Nilotinib as an Inhibitor of Inflammation in Acute Myeloid Leukemia. Journal of Medicinal Chemistry. 65(18). 12014–12030. 7 indexed citations
2.
Scott, Mary T., Karen Dunn, Eric R. Kalkman, et al.. (2021). ULK1 inhibition promotes oxidative stress–induced differentiation and sensitizes leukemic stem cells to targeted therapy. Science Translational Medicine. 13(613). eabd5016–eabd5016. 35 indexed citations
3.
Birchall, Kristian, et al.. (2018). Design of the LifeArc Index Set and Retrospective Review of Its Performance: A Collection for Sharing. SLAS DISCOVERY. 24(3). 332–345. 5 indexed citations
4.
McNeil, Ewan M., Katy R. Astell, Steven Shave, et al.. (2015). Inhibition of the ERCC1–XPF structure-specific endonuclease to overcome cancer chemoresistance. DNA repair. 31. 19–28. 61 indexed citations
5.
Chapman, Timothy M., Claire Wallace, Preeti Bakrania, et al.. (2015). N-Hydroxyimides and hydroxypyrimidinones as inhibitors of the DNA repair complex ERCC1–XPF. Bioorganic & Medicinal Chemistry Letters. 25(19). 4104–4108. 19 indexed citations
6.
Mpamhanga, Chido, et al.. (2015). Pharmacological Inhibition of ULK1 Kinase Blocks Mammalian Target of Rapamycin (mTOR)-dependent Autophagy. Journal of Biological Chemistry. 290(18). 11376–11383. 299 indexed citations
7.
Mpamhanga, Chido, et al.. (2015). Pharmacological inhibition of ULK1 kinase blocks mammalian target of rapamycin (mTOR)-dependent autophagy.. Journal of Biological Chemistry. 290(48). 28726–28726. 68 indexed citations
8.
Guzman, Juan, Dimitrios Evangelopoulos, Antima Gupta, et al.. (2013). Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay. BMJ Open. 3(6). e002672–e002672. 68 indexed citations
9.
White, R. Clyde, Barbara Saxty, Jonathan M. Large, Catherine Kettleborough, & Andrew P. Jackson. (2013). Identification of Small-Molecule Inhibitors of the Ribonuclease H2 Enzyme. SLAS DISCOVERY. 18(5). 610–620. 10 indexed citations
10.
Chapman, Timothy M., Nathalie Bouloc, Roger S. Buxton, et al.. (2012). Substituted aminopyrimidine protein kinase B (PknB) inhibitors show activity against Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry Letters. 22(9). 3349–3353. 42 indexed citations
11.
Roche, Marc de la, Trevor J. Rutherford, Deepti Gupta, et al.. (2012). An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acid. Nature Communications. 3(1). 680–680. 106 indexed citations
12.
Gonçalves, Victor, J.A. Brannigan, David Whalley, et al.. (2012). Discovery of Plasmodium vivaxN-Myristoyltransferase Inhibitors: Screening, Synthesis, and Structural Characterization of their Binding Mode. Journal of Medicinal Chemistry. 55(7). 3578–3582. 60 indexed citations
13.
Lougheed, Kathryn, Simon A. Osborne, Barbara Saxty, et al.. (2011). Effective inhibitors of the essential kinase PknB and their potential as anti-mycobacterial agents. Tuberculosis. 91(4). 277–286. 62 indexed citations
14.
Saxty, Barbara, et al.. (2001). Inactivation of platelet‐derived growth factor‐BB following modification by ADP‐ribosyltransferase. British Journal of Pharmacology. 133(8). 1219–1226. 26 indexed citations
15.
Kefalas, Panagiotis, et al.. (1999). Chemotaxin‐dependent translocation of immunoreactive ADP‐ribosyltransferase‐1 to the surface of human neutrophil polymorphs. European Journal of Biochemistry. 259(3). 866–871. 8 indexed citations
16.
Saxty, Barbara, et al.. (1998). Inhibition of chemotaxis in A7r5 rat smooth muscle cells by a novel panel of inhibitors. British Journal of Pharmacology. 125(1). 152–158. 3 indexed citations
17.
Saunders, Philippa T. K., et al.. (1996). Expression of protamine P2 in the testis of the common marmoset and man visualized using non‐radioactive in‐situ hybridization. International Journal of Andrology. 19(4). 212–219. 15 indexed citations
18.
Dolle, Roland E., Lawrence I. Kruse, Drake S. Eggleston, et al.. (1995). Synthesis of Novel Thiol-Containing Citric Acid Analogs. Kinetic Evaluation of These and Other Potential Active-Site-Directed and Mechanism-Based Inhibitors of ATP Citrate Lyase. Journal of Medicinal Chemistry. 38(3). 537–543. 15 indexed citations
19.
Elshourbagy, Nabil A., et al.. (1992). Cloning and expression of a human ATP‐citrate lyase cDNA. European Journal of Biochemistry. 204(2). 491–499. 66 indexed citations
20.
Wells, Timothy N. C. & Barbara Saxty. (1992). Redox control of catalysis in ATP‐citrate lyase from rat liver. European Journal of Biochemistry. 204(1). 249–255. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paola Lo Surdo Breakdown of academic impact, for papers by John P. Durham Breakdown of academic impact, for papers by Dasheng Wang Breakdown of academic impact, for papers by Gregory Tombline Breakdown of academic impact, for papers by Pierre Beauparlant Breakdown of academic impact, for papers by Yigang Wang Breakdown of academic impact, for papers by Raffaele Frazzi Breakdown of academic impact, for papers by Benjamin T. Vroman Breakdown of academic impact, for papers by Halime Kalkavan Breakdown of academic impact, for papers by Mustapha Aoubala
Rankless by CCL
2026